These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 30332560)

  • 21. Functionally impaired plasmacytoid dendritic cells and non-haematopoietic sources of type I interferon characterize human autoimmunity.
    Psarras A; Alase A; Antanaviciute A; Carr IM; Md Yusof MY; Wittmann M; Emery P; Tsokos GC; Vital EM
    Nat Commun; 2020 Dec; 11(1):6149. PubMed ID: 33262343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent advances in the genetics of systemic lupus erythematosus.
    Flesher DL; Sun X; Behrens TW; Graham RR; Criswell LA
    Expert Rev Clin Immunol; 2010 May; 6(3):461-79. PubMed ID: 20441431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Type I interferons (alpha/beta) in immunity and autoimmunity.
    Theofilopoulos AN; Baccala R; Beutler B; Kono DH
    Annu Rev Immunol; 2005; 23():307-36. PubMed ID: 15771573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Pathogenesis, Molecular Mechanisms, and Therapeutic Potential of the Interferon Pathway in Systemic Lupus Erythematosus and Other Autoimmune Diseases.
    Ramaswamy M; Tummala R; Streicher K; Nogueira da Costa A; Brohawn PZ
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Type I interferonopathies. Systemic inflammatory diseases triggered by type I interferons].
    Günther C; Schmidt F; König N; Lee-Kirsch MA
    Z Rheumatol; 2016 Mar; 75(2):134-40. PubMed ID: 26744186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Type I interferon signature in systemic lupus erythematosus.
    Bezalel S; Guri KM; Elbirt D; Asher I; Sthoeger ZM
    Isr Med Assoc J; 2014 Apr; 16(4):246-9. PubMed ID: 24834763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endogenous type I interferon inducers in autoimmune diseases.
    Finke D; Eloranta ML; Rönnblom L
    Autoimmunity; 2009 May; 42(4):349-52. PubMed ID: 19811298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting Toll-like receptors for treatment of SLE.
    Horton CG; Pan ZJ; Farris AD
    Mediators Inflamm; 2010; 2010():. PubMed ID: 20886024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Type I interferon production by nucleic acid-stimulated dendritic cells.
    Kaisho T
    Front Biosci; 2008 May; 13():6034-42. PubMed ID: 18508640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interferon regulatory factors: beyond the antiviral response and their link to the development of autoimmune pathology.
    Santana-de Anda K; Gómez-Martín D; Díaz-Zamudio M; Alcocer-Varela J
    Autoimmun Rev; 2011 Dec; 11(2):98-103. PubMed ID: 21872684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interferon lambda in inflammation and autoimmune rheumatic diseases.
    Goel RR; Kotenko SV; Kaplan MJ
    Nat Rev Rheumatol; 2021 Jun; 17(6):349-362. PubMed ID: 33907323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interfering with baffled B cells at the lupus tollway: Promises, successes, and failed expectations.
    Singh N; Kumar B; Aluri V; Lenert P
    J Allergy Clin Immunol; 2016 May; 137(5):1325-33. PubMed ID: 26953155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nucleic acid sensing receptors in systemic lupus erythematosus: development of novel DNA- and/or RNA-like analogues for treating lupus.
    Lenert P
    Clin Exp Immunol; 2010 Aug; 161(2):208-22. PubMed ID: 20456414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TLRs and interferons: a central paradigm in autoimmunity.
    Kono DH; Baccala R; Theofilopoulos AN
    Curr Opin Immunol; 2013 Dec; 25(6):720-7. PubMed ID: 24246388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interrelationship of dendritic cells, type 1 interferon system, regulatory T cells and toll-like receptors and their role in lichen planus and lupus erythematosus -- a literature review.
    Trucci VM; Salum FG; Figueiredo MA; Cherubini K
    Arch Oral Biol; 2013 Oct; 58(10):1532-40. PubMed ID: 23845753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of interferons in SLE.
    Bengtsson AA; Rönnblom L
    Best Pract Res Clin Rheumatol; 2017 Jun; 31(3):415-428. PubMed ID: 29224681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Taking the STING out of TLR-driven autoimmune diseases: good, bad, or indifferent?
    Pawaria S; Sharma S; Baum R; Nündel K; Busto P; Gravallese EM; Fitzgerald KA; Marshak-Rothstein A
    J Leukoc Biol; 2017 Jan; 101(1):121-126. PubMed ID: 27531928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferons and autoimmune disorders.
    Meyer O
    Joint Bone Spine; 2009 Oct; 76(5):464-73. PubMed ID: 19773191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Type I Interferon and the Spectrum of Susceptibility to Viral Infection and Autoimmune Disease: A Shared Genomic Signature.
    Sugrue JA; Bourke NM; O'Farrelly C
    Front Immunol; 2021; 12():757249. PubMed ID: 34917078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The emerging role of interferon in human systemic lupus erythematosus.
    Baechler EC; Gregersen PK; Behrens TW
    Curr Opin Immunol; 2004 Dec; 16(6):801-7. PubMed ID: 15511676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.